These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30760313)

  • 1. Integrative analysis based on survival associated co-expression gene modules for predicting Neuroblastoma patients' survival time.
    Han Y; Ye X; Cheng J; Zhang S; Feng W; Han Z; Zhang J; Huang K
    Biol Direct; 2019 Feb; 14(1):4. PubMed ID: 30760313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of molecular features with clinical information for predicting outcomes for neuroblastoma patients.
    Han Y; Ye X; Wang C; Liu Y; Zhang S; Feng W; Huang K; Zhang J
    Biol Direct; 2019 Aug; 14(1):16. PubMed ID: 31443736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of RNA-seq and microarray-based models for clinical endpoint prediction.
    Zhang W; Yu Y; Hertwig F; Thierry-Mieg J; Zhang W; Thierry-Mieg D; Wang J; Furlanello C; Devanarayan V; Cheng J; Deng Y; Hero B; Hong H; Jia M; Li L; Lin SM; Nikolsky Y; Oberthuer A; Qing T; Su Z; Volland R; Wang C; Wang MD; Ai J; Albanese D; Asgharzadeh S; Avigad S; Bao W; Bessarabova M; Brilliant MH; Brors B; Chierici M; Chu TM; Zhang J; Grundy RG; He MM; Hebbring S; Kaufman HL; Lababidi S; Lancashire LJ; Li Y; Lu XX; Luo H; Ma X; Ning B; Noguera R; Peifer M; Phan JH; Roels F; Rosswog C; Shao S; Shen J; Theissen J; Tonini GP; Vandesompele J; Wu PY; Xiao W; Xu J; Xu W; Xuan J; Yang Y; Ye Z; Dong Z; Zhang KK; Yin Y; Zhao C; Zheng Y; Wolfinger RD; Shi T; Malkas LH; Berthold F; Wang J; Tong W; Shi L; Peng Z; Fischer M
    Genome Biol; 2015 Jun; 16(1):133. PubMed ID: 26109056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of potential driver genes with genomic alterations predicts survival of high-risk neuroblastoma patients.
    Suo C; Deng W; Vu TN; Li M; Shi L; Pawitan Y
    Biol Direct; 2018 Jul; 13(1):14. PubMed ID: 30012197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting clinical outcomes in neuroblastoma with genomic data integration.
    Baali I; Acar DAE; Aderinwale TW; HafezQorani S; Kazan H
    Biol Direct; 2018 Sep; 13(1):20. PubMed ID: 30621745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TSUNAMI: Translational Bioinformatics Tool Suite for Network Analysis and Mining.
    Huang Z; Han Z; Wang T; Shao W; Xiang S; Salama P; Rizkalla M; Huang K; Zhang J
    Genomics Proteomics Bioinformatics; 2021 Dec; 19(6):1023-1031. PubMed ID: 33705981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Condition-specific gene co-expression network mining identifies key pathways and regulators in the brain tissue of Alzheimer's disease patients.
    Xiang S; Huang Z; Wang T; Han Z; Yu CY; Ni D; Huang K; Zhang J
    BMC Med Genomics; 2018 Dec; 11(Suppl 6):115. PubMed ID: 30598117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-Module: A novel fusion measure to associate co-expressed gene modules from condition-specific expression profiles.
    Kakati T; Bhattacharyya DK; Kalita JK
    J Biosci; 2020; 45():. PubMed ID: 32098912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of a multi-signature ensemble classifier predicting neuroblastoma patients' outcome.
    Cornero A; Acquaviva M; Fardin P; Versteeg R; Schramm A; Eva A; Bosco MC; Blengio F; Barzaghi S; Varesio L
    BMC Bioinformatics; 2012 Mar; 13 Suppl 4(Suppl 4):S13. PubMed ID: 22536959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Classification Substitutes for the Prognostic Variables Stage, Age, and MYCN Status in Neuroblastoma Risk Assessment.
    Rosswog C; Schmidt R; Oberthuer A; Juraeva D; Brors B; Engesser A; Kahlert Y; Volland R; Bartenhagen C; Simon T; Berthold F; Hero B; Faldum A; Fischer M
    Neoplasia; 2017 Dec; 19(12):982-990. PubMed ID: 29091799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting survival times for neuroblastoma patients using RNA-seq expression profiles.
    Grimes T; Walker AR; Datta S; Datta S
    Biol Direct; 2018 May; 13(1):11. PubMed ID: 29848365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cure Weibull gamma-frailty survival model and its application to exploring the prognosis factors of neuroblastoma.
    Dokhi M; Ohtaki M; Hiyama E
    Hiroshima J Med Sci; 2009 Mar; 58(1):25-35. PubMed ID: 19400554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-expression modules construction by WGCNA and identify potential prognostic markers of uveal melanoma.
    Wan Q; Tang J; Han Y; Wang D
    Exp Eye Res; 2018 Jan; 166():13-20. PubMed ID: 29031853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overall survival for neuroblastoma in South Africa between 2000 and 2014.
    Van Heerden J; Hendricks M; Geel J; Sartorius B; Hadley GP; Du Plessis J; Büchner A; Naidu G; Van Emmenes B; Van Zyl A; Kruger M
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27944. PubMed ID: 31368239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene Co-expression Network Analysis and Linking Modules to Phenotyping Response in Plants.
    Du Q; Campbell MT; Yu H; Liu K; Walia H; Zhang Q; Zhang C
    Methods Mol Biol; 2022; 2539():261-268. PubMed ID: 35895209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclassification and individual survival time prediction from gene expression data of neuroblastoma patients by using CASPAR.
    Oberthuer A; Kaderali L; Kahlert Y; Hero B; Westermann F; Berthold F; Brors B; Eils R; Fischer M
    Clin Cancer Res; 2008 Oct; 14(20):6590-601. PubMed ID: 18927300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival after relapse in children with solid tumors: a follow-up study from the Italian off-therapy registry.
    Ceschel S; Casotto V; Valsecchi MG; Tamaro P; Jankovic M; Hanau G; Fossati F; Pillon M; Rondelli R; Sandri A; Silvestri D; Haupt R; Cuttini M
    Pediatr Blood Cancer; 2006 Oct; 47(5):560-6. PubMed ID: 16395684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival of children with neuroblastoma prior to the neuroblastoma screening project in Germany.
    Burkhardt-Hammer T; Spix C; Brenner H; Kaatsch P; Berthold F; Hero B; Michaelis J
    Med Pediatr Oncol; 2002 Sep; 39(3):156-62. PubMed ID: 12210443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distillation of the clinical algorithm improves prognosis by multi-task deep learning in high-risk Neuroblastoma.
    Maggio V; Chierici M; Jurman G; Furlanello C
    PLoS One; 2018; 13(12):e0208924. PubMed ID: 30532223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of glioblastoma gene prognosis modules based on weighted gene co-expression network analysis.
    Xu P; Yang J; Liu J; Yang X; Liao J; Yuan F; Xu Y; Liu B; Chen Q
    BMC Med Genomics; 2018 Nov; 11(1):96. PubMed ID: 30382873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.